Page last updated: 2024-09-03

ramatroban and adenosine diphosphate

ramatroban has been researched along with adenosine diphosphate in 2 studies

Compound Research Comparison

Studies (ramatroban)	Trials (ramatroban)	Recent Studies (post-2010) (ramatroban)	Studies (adenosine diphosphate)	Trials (adenosine diphosphate)	Recent Studies (post-2010) (adenosine diphosphate)
142	10	28	23,989	498	3,114

Protein Interaction Comparison

Protein	Taxonomy	adenosine diphosphate (IC50)
Chain A, Kinesin-like protein KIF11	Homo sapiens (human)	0.45
Heat shock 70 kDa protein 1A	Homo sapiens (human)	0.5
Sensor protein kinase WalK	Staphylococcus aureus	7.189

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (50.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Böshagen, H; Fiedler, VB; Perzborn, E; Rosentreter, U; Sander, E; Seuter, F; Stasch, JP; Weber, H	1
Arima, J; Ayukawa, O; Iguro, Y; Kariyazono, H; Majima, HJ; Masuda, H; Nakamura, K; Onimaru, S; Sakata, R; Yamada, K	1

Other Studies

2 other study(ies) available for ramatroban and adenosine diphosphate

Article	Year
Characterization of Bay U 3405, a novel thromboxane A2/endoperoxide receptor antagonist. Stroke, 1990, Volume: 21, Issue:12 Suppl Topics: Adenosine Diphosphate; Animals; Aorta; Arachidonic Acid; Arachidonic Acids; Binding, Competitive; Carbazoles; Cerebrovascular Disorders; Collagen; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Rats; Rats, Inbred SHR; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboembolism; Thromboxanes; Vasoconstriction	1990
Evaluation of anti-platelet aggregatory effects of aspirin, cilostazol and ramatroban on platelet-rich plasma and whole blood. Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2004, Volume: 15, Issue:2 Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine Diphosphate; Arachidonic Acid; Aspirin; Carbazoles; Cilostazol; Collagen; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclooxygenase Inhibitors; Humans; Microscopy, Confocal; Phosphodiesterase Inhibitors; Plasma; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Thromboxane A2, Prostaglandin H2; Reproducibility of Results; Sulfonamides; Tetrazoles	2004

Article

Year

Characterization of Bay U 3405, a novel thromboxane A2/endoperoxide receptor antagonist.

Stroke, 1990, Volume: 21, Issue:12 Suppl

Topics: Adenosine Diphosphate; Animals; Aorta; Arachidonic Acid; Arachidonic Acids; Binding, Competitive; Carbazoles; Cerebrovascular Disorders; Collagen; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Rats; Rats, Inbred SHR; Receptors, Prostaglandin; Receptors, Thromboxane; Sulfonamides; Thromboembolism; Thromboxanes; Vasoconstriction

1990

Evaluation of anti-platelet aggregatory effects of aspirin, cilostazol and ramatroban on platelet-rich plasma and whole blood.

Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2004, Volume: 15, Issue:2

Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenosine Diphosphate; Arachidonic Acid; Aspirin; Carbazoles; Cilostazol; Collagen; Cyclic Nucleotide Phosphodiesterases, Type 3; Cyclooxygenase Inhibitors; Humans; Microscopy, Confocal; Phosphodiesterase Inhibitors; Plasma; Platelet Aggregation; Platelet Aggregation Inhibitors; Receptors, Thromboxane A2, Prostaglandin H2; Reproducibility of Results; Sulfonamides; Tetrazoles

2004